Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.50 |
| ▸ | RELA | Q04206 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16706004 | 0.84 | CYP1A2 (0.42) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL16706018 | 0.80 | MEN1 (0.35) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL1509663 | 0.74 | RAB9A (0.54) | CYP1A2RAB9ANPC1NFKB1NFKB2 | |
| SCHEMBL11978713 | 0.71 | L3MBTL1 (0.54) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL2616801 | 0.70 | RAB9A (0.61) | CYP1A2RAB9ANPC1NFKB1NFKB2 | |
| SCHEMBL12422698 | 0.70 | CCR1 (0.35) | — | |
| SCHEMBL29392 | 0.69 | — | — | |
| SCHEMBL17055533 | 0.69 | RAB9A (0.58) | CYP1A2RAB9ANPC1NFKB1NFKB2 | |
| SCHEMBL5680537 | 0.69 | CYP1A2 (1.00) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL2117282 | 0.67 | NPC1 (1.00) | RAB9ANPC1NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9755155-B2 | Organic compounds containing squaric acid or croconic acid moieties for application in electronic devices | SONY CORPORATION (JP) | 2017-09-05 | — | — | US | disclosed |
| US-20150133678-A1 | ORGANIC COMPOUNDS CONTAINING SQUARIC ACID OR CROCONIC ACID MOIETIES FOR APPLICATION IN ELECTRONIC DEVICES | SONY CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133678-A1 | ORGANIC COMPOUNDS CONTAINING SQUARIC ACID OR CROCONIC ACID MOIETIES FOR APPLICATION IN ELECTRONIC DEVICES | SQLE, ACSL1, ACSL3 | CYP1A1 785/4885CYP1A2 374/4885CYP1B1 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.